[Experimental study of tissue-engineered heart tissue using type I collagen as scaffold]
- PMID: 15200919
[Experimental study of tissue-engineered heart tissue using type I collagen as scaffold]
Abstract
Objective: To construct tissue-engineered heart tissue (EHT) using liquid collagen as scaffold.
Methods: Neonatal rat cardiac myocytes were isolated, cultured, and mixed with liquid collagen type I and matrix factors and then cast in circular molds to construct circular cardiac myocytes/collagen strand. After a 7-day culture in circular molds, the strands were removed, and subjected to 10% static stretch for another 7 days. Microscopy and transmission electron microscopy, routine HE staining and immunohistochemical staining were used to analyze the engineered heart tissue.
Results: Beating areas could be seen on the surface of the EHTs at the second day after stretching; more beating areas could be seen thereafter. These areas beat stronger and stronger, and finally came to synchronzation. Histological and immunohistochemical analyses showed that the cardiac myocytes in the EHTs distributed evenly in the whole strand and the majority of the cells, with elongated nuclei, stretched along the stretching direction. The morphology of EHTs resembled that of the native adult cardiac tissue. Transmission electron microscopy revealed that the cardiac myocytes in EHTs contained arranged myofibrils oriented parallel to the longitudinal cell axis. Clearly defined sarcomeres and Z lines were observed.
Conclusion: Liquid type I collagen is a good scaffold for generation of EHTs similar to the native heart tissue.
Similar articles
-
Construction of a unidirectionally beating 3-dimensional cardiac muscle construct.J Heart Lung Transplant. 2005 Aug;24(8):1091-7. doi: 10.1016/j.healun.2004.07.010. J Heart Lung Transplant. 2005. PMID: 16102445
-
[Experimental study of implantable engineered liver tissue using type I collagen gel as scaffold].Zhonghua Yi Xue Za Zhi. 2007 Aug 7;87(29):2065-8. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17925181 Chinese.
-
Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.Circulation. 2006 Jul 4;114(1 Suppl):I72-8. doi: 10.1161/CIRCULATIONAHA.105.001560. Circulation. 2006. PMID: 16820649
-
Cardiac tissue engineering.Transpl Immunol. 2002 May;9(2-4):315-21. doi: 10.1016/s0966-3274(02)00011-4. Transpl Immunol. 2002. PMID: 12180846 Review.
-
Engineered heart tissue for regeneration of diseased hearts.Biomaterials. 2004 Apr;25(9):1639-47. doi: 10.1016/s0142-9612(03)00521-0. Biomaterials. 2004. PMID: 14697865 Review.
Cited by
-
Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.Biomatter. 2012 Jan-Mar;2(1):1-14. doi: 10.4161/biom.19429. Biomatter. 2012. PMID: 23507781 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous